Trial
NCT00531856
Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients
Phase IIWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Mallinckrodt
Collaborators
—
Condition
Kidney Transplantation
Intervention
Inhaled carbon monoxide
Why stopped
Clinical Hold pending additional data review and protocol amendment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-19